.After antibody-drug conjugate (ADC) expert Seagen was marketed to Pfizer in 2015 for an immense $43...
.On the heels of a period 3 win that fell short to impress clients, Ironwood Pharmaceuticals is back...
.Don't stop Monte Rosa Therapies now. The Boston-based biotech is actually having a ball after signi...
.Accept to this week's Chutes & Ladders, our roundup of substantial leadership hirings, shootings...
.Celebrating his firm's upsized initial public offering (IPO), Septerna chief executive officer Jeff...
.AbbVie has gone back to the source of its own antipsychotic goliath Vraylar searching for an additi...
.GenSight Biologics is actually weeks far from losing amount of money. Once again. The biotech only ...
.Monopar Rehabs is actually bouncing back a medication from the scrap heap of AstraZeneca's unusual ...
.With new records out on Arcus Biosciences' experimental HIF-2a prevention, one group of experts fig...
.After developing a genetics treatment partnership with Dyno Therapeutics in 2020, Roche is back for...